What it is
A neutral identity description: sequence class, common research naming, and the form in which it is supplied. No use statement of any kind.
Why researchers study it
A short, sourced statement of why laboratories study the material, written as a description of research activity rather than of results.
Mechanism being investigated
The mechanism under investigation, framed explicitly as 'being investigated'. A mechanism is never presented as an established outcome.
Regulatory status
The material's regulatory category — for example research-use-only material, investigational substance, or approved drug in a named jurisdiction — with the distinction made explicit. Category statements are sourced, never assumed.
Applicable supplier documentation
Where a participating supplier publishes product documentation or a lot-specific certificate of analysis, the profile links to that supplier's current official page. Peptide King does not restate, summarise, or warrant supplier product data.
Evidence levels
- Cell / in vitro
Findings from cell or test-system work, labelled as such, with the source cited. Lowest predictive weight for outcomes in people.
- Animal / in vivo
Findings from animal work, labelled as such. Species differences are stated wherever they are known.
- Human / clinical
Only included where authorised clinical research exists, with design, size, and limitations stated. Absence of human evidence is stated plainly rather than left blank.
Limitations and information gaps
- Known gaps in the published record, stated directly.
- Absence of safety characterisation, where that is the case.
- Where evidence is limited to cell or animal work, that limit is written into the profile rather than implied.
- A profile is a literature summary. It is not a safety assessment, an efficacy finding, or an endorsement.
Marketing status
What you can say about this profile
GREEN — approved
- Research peptides supplied for laboratory research use only.
- Not for human or veterinary use.
- Describing what is being investigated, with the evidence level named.
- Linking to the applicable supplier's current official documentation.
- Clear affiliate disclosure next to any referral link.
YELLOW — context required
- Citing a study: state the evidence level and do not generalise beyond the population studied.
- Mentioning a mechanism: keep 'under investigation' framing; never convert it into a benefit.
- Quoting analytical data: link the specific lot document rather than asserting a figure.
- Comparing materials: descriptive comparisons only, never 'better for' language.
RED — prohibited
- Any human or veterinary use framing, including dosing, administration, or preparation for use.
- Disease treatment, prevention, diagnosis, therapeutic or medical benefit claims.
- Weight, muscle, anti-aging, recovery, performance or body-transformation claims.
- Safety or side-effect reassurance.
- Purity, potency, testing or approval claims not sourced from the supplier's current official documentation.
- Testimonials describing personal use, and income claims of any kind.
References
Primary literature citations
Each factual statement carries a citation to a public source. Uncited statements are not published.
Regulatory source documents
Category and status statements link to the issuing authority's own current materials.